| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $464.1M | +20.7% | +10.5% |
| Cost of Revenue | $312.4M | +19.5% | +14.6% |
| Gross Profit | $151.6M | +23.1% | +3.0% |
| R&D Expense | $19.8M | -3.3% | +8.2% |
| SG&A Expense | $70.2M | +4.8% | -0.7% |
| Operating Income | $58.8M | +77.8% | +1.4% |
| Pre-tax Income | $48.1M | +87.3% | -2.5% |
| Income Tax | $9.4M | +83.3% | -18.5% |
| Net Income | $38.7M | +88.3% | +2.3% |
| EPS (Basic) | $2.31 | +89.3% | +2.2% |
| EPS (Diluted) | $2.22 | +88.1% | +0.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $336.7M | +170.6% | +231.3% |
| Accounts Receivable | $833.2M | +0.6% | +18.4% |
| Inventory | $452.6M | -0.3% | +2.4% |
| Current Assets | $1.69B | +14.2% | +27.4% |
| Total Assets | $2.52B | +9.7% | +18.4% |
| Current Liabilities | $535.4M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $79.3M | +363.0% | — |
| Capital Expenditures | $13.7M | +95.1% | — |
| Investing Cash Flow | -$21.4M | -95.9% | — |
| Financing Cash Flow | $172.6M | +1316.5% | — |
| Free Cash Flow | $65.6M | +549.2% | — |
| -23.9% |
| Long-term Debt | $1.00B | +127.0% | +111.5% |
| Total Liabilities | $1.68B | +23.9% | +28.5% |
| Stockholders' Equity | $845.5M | -10.6% | +2.4% |